InfoBionic, a Lowell, MA-based digital health company focused on creating patient monitoring solutions for chronic disease management, closed the first tranche of a $17m Series B financing.
The round was led by Safeguard Scientifics (NYSE: SFE) with participation from previous investors Mass Medical Angels (MA2), Broadview Ventures, TiE, Beta Fund, Boardwalk, Launchpad Venture Group, Cherrystone TCA, HTC, Boynton, and Keiretsu. As part of this financing, Safeguard Scientifics acquired 20% primary ownership of InfoBionic and Mr. Wiegman will join InfoBionic’s board of directors.
The company intends to use the funds to commercialize its platform.
Led by Nancy Briefs, CEO, InfoBionic provides the MoMe™ System, a cloud-based remote patient monitoring platform for cardiac arrhythmia detection, in Europe and the United States. It features tools for analysis, a patient device, and a physician user interface for remote management.